Here, we established a stable ANLN-overexpressing cell line (Fig. S10A) to further evaluate the effects of two clinically used drugs including simvastatin and verteporfin on ICC tumors in vivo. This evidence concerns the gene ANLN and intrahepatic cholangiocarcinoma.